tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Alec Stranahan, 12 are a BUY (46.15%), 6 are a HOLD (23.08%), 8 are a SELL (30.77%).
Analyst Alec Stranahan, currently employed at BAML, carries an average stock price target met ratio of 61.19% that have a potential upside of 31.01% achieved within 151 days.
Alec Stranahan’s has documented 52 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RVMD, Revolution Medicines at 16-Jul-2024.
Analyst best performing recommendations are on NVAX (NOVAVAX).
The best stock recommendation documented was for NVAX (NOVAVAX) at 5/10/2024. The price target of $12 was fulfilled within 3 days with a profit of $3.12 (35.14%) receiving and performance score of 117.12.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
4
$2.31 (136.69%)
4
2 months 23 days ago
0/6 (0%)
$2.47 (161.44%)
Hold
16
1 years 8 months 22 days ago
0/3 (0%)
$11.08 (225.20%)
Buy
6
$4.31 (255.03%)
13
1 years 8 months 23 days ago
3/14 (21.43%)
$3.49 (139.04%)
56
Buy
15
$13.31 (787.57%)
19
1 years 11 months 3 days ago
1/4 (25%)
$10.56 (237.84%)
185
Buy
14
$12.31 (728.40%)
14
2 years 2 months 20 days ago
0/3 (0%)
$10.2 (268.42%)
Which stock is Alec Stranahan is most bullish on?
Which stock is Alec Stranahan is most reserved on?
What Year was the first public recommendation made by Alec Stranahan?
